Abeona Therapeutics Inc
ABEO
Abeona Therapeutics Inc AI Insights
Informational only. Not investment advice.Snapshot
- Net income TTM of 82.4M on just 400K revenue driven by 90M EBITDA - likely one-time licensing/milestone income, not recurring operations.[Net Income TTM]
- FCF burn of -82.4M TTM with 82.9M cash leaves ~12 months runway without additional financing or milestone payments.[Free Cash Flow TTM]
- Revenue declined -55% 3Y CAGR while R&D of 29.1M continues - pre-commercial biotech dependent on pipeline catalysts.[Total Revenue 3yr Growth TTM]
Watch Triggers
- Cash and Equivalents: Falls below 50M — Signals imminent dilutive financing within 6 months at current burn rate.
- Total Revenue TTM: Exceeds 10M — Would indicate commercial launch or recurring partnership revenue vs one-time milestones.
- Free Cash Flow TTM: Improves to above -50M — Extends runway materially, reduces near-term dilution risk.
Bull Case
Positive net income (82.4M) and EBITDA (89.9M) TTM suggest recent milestone/licensing deal - validates pipeline value if recurring.
Trading at 1.7x book (171.2M equity) with 193.9M working capital provides downside cushion if pipeline advances.
Bear Case
Negative gross margin (-47%) and -208% operating margin indicate core operations are deeply unprofitable without one-time income.
Revenue declining -55% 3Y CAGR with minimal commercial traction (400K TTM) - binary pipeline risk with no revenue diversification.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage ABEO's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway exhaustion within 12-18 months will force dilutive financing or partnership deal.
- 82.9M cash vs 82.4M annual FCF burn
- No recurring revenue base (400K TTM)
- Ongoing R&D spend of 29.1M annually
Public Strategies Rankings
See how Abeona Therapeutics Inc ranks across different investment strategies.
Leverage ABEO's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
ABEO Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$271.21M | — | ||
$212.44M | — | ||
4.7 | — | ||
$400,000 | — | ||
$1.06 | — | ||
-20,802% | -20802.3% | — | |
20,588% | +20587.5% | — | |
$-82.36M | — | ||
0.76 | +285.4% | — | |
Beta 5Y (Monthly) | unknown | — |
ABEO Dividend History
ABEO Stock Splits
ABEO SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/12/25 | 09/30/25 | 10-Q | |
08/14/25 | 06/30/25 | 10-Q | |
05/15/25 | 03/31/25 | 10-Q | |
03/20/25 | 12/31/24 | Unknown | |
11/14/24 | 09/30/24 | 10-Q | |
08/12/24 | 06/30/24 | 10-Q | |
05/15/24 | 03/31/24 | 10-Q | |
03/18/24 | 12/31/23 | 10-K | |
03/20/25 | 12/31/23 | 10-K | |
11/13/23 | 09/30/23 | 10-Q | |
08/08/23 | 06/30/23 | 10-Q | |
05/11/23 | 03/31/23 | 10-Q | |
03/29/23 | 12/31/22 | 10-K | |
11/14/22 | 09/30/22 | 10-Q | |
08/11/22 | 06/30/22 | 10-Q | |
05/13/22 | 03/31/22 | 10-Q | |
03/31/22 | 12/31/21 | 10-K | |
11/15/21 | 09/30/21 | 10-Q | |
07/28/21 | 06/30/21 | 10-Q | |
05/17/21 | 03/31/21 | 10-Q | |
03/24/21 | 12/31/20 | 10-K | |
11/09/20 | 09/30/20 | 10-Q | |
08/10/20 | 06/30/20 | 10-Q | |
05/06/20 | 03/31/20 | 10-Q | |
03/16/20 | 12/31/19 | 10-K | |
11/12/19 | 09/30/19 | 10-Q | |
08/09/19 | 06/30/19 | 10-Q | |
05/10/19 | 03/31/19 | 10-Q | |
03/18/19 | 12/31/18 | 10-K | |
11/09/18 | 09/30/18 | 10-Q | |
08/09/18 | 06/30/18 | 10-Q | |
05/10/18 | 03/31/18 | 10-Q | |
03/16/18 | 12/31/17 | 10-K | |
11/14/17 | 09/30/17 | 10-Q | |
08/14/17 | 06/30/17 | 10-Q | |
05/15/17 | 03/31/17 | 10-Q | |
03/30/17 | 12/31/16 | 10-K | |
11/14/16 | 09/30/16 | 10-Q | |
08/15/16 | 06/30/16 | 10-Q | |
05/16/16 | 03/31/16 | 10-Q | |
03/30/16 | 12/31/15 | 10-K | |
11/16/15 | 09/30/15 | 10-Q | |
08/14/15 | 06/30/15 | 10-Q | |
05/14/15 | 03/31/15 | 10-Q | |
03/31/15 | 12/31/14 | 10-K | |
11/14/14 | 09/30/14 | 10-Q | |
08/14/14 | 06/30/14 | 10-Q | |
08/14/15 | 06/30/14 | 10-Q/A | |
05/12/14 | 03/31/14 | 10-Q | |
03/26/14 | 12/31/13 | 10-K | |
11/14/13 | 09/30/13 | 10-Q | |
08/14/13 | 06/30/13 | 10-Q | |
05/15/13 | 03/31/13 | 10-Q | |
03/20/13 | 12/31/12 | 10-K | |
11/14/12 | 09/30/12 | 10-Q | |
08/14/12 | 06/30/12 | 10-Q | |
05/15/12 | 03/31/12 | 10-Q | |
03/23/12 | 12/31/11 | 10-K | |
11/14/11 | 09/30/11 | 10-Q | |
08/15/11 | 06/30/11 | 10-Q | |
05/16/11 | 03/31/11 | 10-Q | |
03/31/11 | 12/31/10 | 10-K | |
11/12/10 | 09/30/10 | 10-Q | |
08/16/10 | 06/30/10 | 10-Q | |
05/17/10 | 03/31/10 | 10-Q | |
03/23/10 | 12/31/09 | 10-K | |
11/16/09 | 09/30/09 | 10-Q | |
08/13/09 | 06/30/09 | 10-Q | |
05/19/09 | 03/30/09 | 10-Q | -- |
03/31/09 | 12/31/08 | 10-K | |
09/30/08 | 09/30/08 | Unknown | -- |
06/30/08 | 06/30/08 | Unknown | -- |
03/31/08 | 03/30/08 | Unknown | -- |
03/31/08 | 12/31/07 | 10-K | |
09/30/07 | 09/30/07 | Unknown | -- |
06/30/07 | 06/30/07 | Unknown | -- |
03/31/07 | 03/31/07 | 8-K | |
12/31/06 | 12/31/06 | Unknown | -- |
09/30/06 | 09/30/06 | Unknown | -- |
08/21/06 | 06/30/06 | 10-Q | |
06/16/06 | 03/30/06 | Unknown | -- |
05/01/06 | 12/31/05 | NT 10-K | |
11/15/05 | 09/30/05 | NT 10-Q | |
08/09/05 | 06/30/05 | 10-Q | |
05/11/05 | 03/30/05 | Unknown | -- |
04/01/05 | 12/31/04 | 10-K | |
11/15/04 | 09/30/04 | 8-K | |
08/16/04 | 06/30/04 | 10-Q | |
05/17/04 | 03/30/04 | Unknown | -- |
03/24/04 | 12/31/03 | 10-K | |
11/14/03 | 09/30/03 | 10-Q | |
08/14/03 | 06/30/03 | 10-Q | |
05/15/03 | 03/30/03 | Unknown | -- |
03/31/03 | 12/31/02 | 10-K | |
11/14/02 | 09/30/02 | 10-Q | |
08/14/02 | 06/30/02 | 10-Q | |
05/15/02 | 03/30/02 | Unknown | -- |
04/02/02 | 12/31/01 | 10-K | |
11/13/01 | 09/30/01 | 10-Q | |
08/14/01 | 06/30/01 | 10-Q | |
05/15/01 | 03/30/01 | Unknown | -- |
04/02/01 | 12/31/00 | 10-K | |
11/14/00 | 09/30/00 | 10-Q | |
08/14/00 | 06/30/00 | 10-Q | |
05/15/00 | 03/30/00 | Unknown | -- |